After 16 long years without a truly viable Alzheimer’s treatment, there’s some hope on the horizon, in a stunning reversal regarding the previously-rejected antibody therapy, aducanumab. The most recent research reveals that high doses of this medication do, in fact, decrease cognitive decline at the beginning stages of Alzheimer’s.
As stated by Rebecca Edelmayer, director of scientific engagement at the Alzheimer’s Association, “It could be a game-changer for the field. It could be one of the first disease-modifying therapies approved for Alzheimer’s disease.”
Biogen, the maker of aducanumab, reports noticeable benefits for dementia patients in many different aspects: activities of daily living, memory, language, and orientation. Biogen introduced its plans to pursue regulatory approval in the U.S., with a longer-term aim of launching the medication throughout the world.
With a predicted request for approval from the FDA as soon as early 2020, the drug is slated to possibly become the first treatment option to actually decrease the clinical decline of Alzheimer’s. Furthermore, it will certainly open doors to some other treatment options that affect amyloid beta plaques, joining other trials that focus on the immune system, inflammation, blood vessels, and synaptic cell health. As uncovering the most beneficial treatment of the disease is a complex endeavor, it is likely that a combination of these treatments will be essential, according to Edelmayer.
The next challenge? Persuading the FDA to approve the treatment after past unsuccessful trials. If approved, aducanumab will first be offered to people who had enrolled in past clinical trials, and hopefully, soon open to other people dealing with all the difficulties of Alzheimer’s as well.
For the almost 6 million senior Americans battling Alzheimer’s (and that number is anticipated to more than double during the next 30 years), along with the loved ones who take care of them, these most recent findings could be life-changing, as there are currently just minimally effective symptom-management medications available. As we look forward to a treatment, we at Atlanta Home Care Partners are prepared to help dementia patients through professional, trained, and experienced caregivers who utilize innovative therapeutic approaches that center on each person’s unique strengths and making sure that each person is living to the fullest possible potential.
For more information regarding highly effective Alzheimer’s treatment and care which helps optimize wellbeing while in the comfort of home, contact the dementia care professionals at Atlanta Home Care Partners at (404) 228-0103 and ask for an in-home consultation or additional useful resources from a trusted memory care provider in Atlanta.